Type 2 & other diabetes

Diabetes, in‐hospital mortality trends and life expectancy loss among a 21.8‐million population in Beijing, China, 2012–2024

Diabet MedPublished Retrospective cohort study

Authors' conclusion

Diabetes was associated with substantially higher in-hospital mortality and smaller mortality improvements. Earlier diagnosis was linked to greater life expectancy loss, with disproportionate losses among women.

Study context

Population
Hospitalised patients in 207 public general hospitals in Beijing serving 21.8 million registered residents, 2012–2024
Participants
452,186 in-hospital deaths
Exposure
Patients with diabetes vs without diabetes
  • Diabetesn = 146,282
Outcome
In-hospital mortality
Follow-up
2012-2024
Methodological detailshospitalisation records from 207 public general hospitals, Joinpoint regression, abridged life tables
  • Hospitalisation records from 207 public general hospitals
  • Joinpoint regression
  • Abridged life tables

Main finding

As reported in the abstract

In-hospital mortality per 1000 admissions

Observational data: associations, not effects.

Further findings

OutcomeDiabetesNo diabetesDifference (years)
Mortality trend, adults ≥75 years · 2012-2019AAPC0.9%−1.2%
pp = 0.082p = 0.026
Mortality trend, adults <75 years · 2012-2019−2.4%−4.0%
Life expectancy (from hospitalisation records)Lower with Diabetes5.0
Life expectancy (from hospitalisation records) — Loss greater with earlier diagnosis; diagnosis at ages 20-24 years: reduction
4.8 years

Mortality trend, adults <75 years · 2012-2019

Declines smaller in patients with diabetes

Life expectancy loss by sex

Loss in women vs men
5.8 vs. 2.4 years

Original publication

Diabetes, in‐hospital mortality trends and life expectancy loss among a 21.8‐million population in Beijing, China, 2012–2024. Diabet Med. Published 6 June 2026. doi:10.1111/dme.70380

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.